FDA Drug Recalls

Recalls / Class II

Class IID-1535-2020

Product

Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.

Brand name
Sulfamethoxazole And Trimethoprim
Generic name
Sulfamethoxazole And Trimethoprim
Active ingredients
Sulfamethoxazole, Trimethoprim
Route
Oral
NDCs
65862-419, 65862-420
FDA application
ANDA090624
Affected lot / code info
Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.

Why it was recalled

Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).

Recalling firm

Firm
Aurobindo Pharma USA Inc.
Manufacturer
Aurobindo Pharma Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
279 Princeton Hightstown Rd, N/A, East Windsor, New Jersey 08520-1401

Distribution

Quantity
5748 bottles
Distribution pattern
Nationwide in the U.S.

Timeline

Recall initiated
2020-08-10
FDA classified
2020-08-21
Posted by FDA
2020-09-02
Terminated
2024-06-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1535-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.